Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Repurposing Low-Dose Clonidine for PTSD in Veterans [Phase 3]

View source ↗

Summary

Clinical trial update indicating ongoing Phase 3 evaluation of low-dose clonidine as a repurposed therapy for posttraumatic stress disorder in veterans; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: PTSD, Posttraumatic Stress Disorder | Phase 3 | Status: RECRUITING